Literature DB >> 20224931

Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects.

Joseph Okombo1, Michael Liebman.   

Abstract

Both a high dietary oxalate intake and increased intestinal absorption appear to be major causes of elevated urine oxalate, a risk factor for kidney stone formation. By favorably altering the gastrointestinal bacterial population, probiotics have the potential to lower oxalate absorption/urinary excretion. This study assessed whether a 4-wk daily consumption of a commercially available probiotic by 11 healthy volunteers (8 females, 3 males), aged 21-36 y, would decrease oxalate absorption. The study involved the ingestion of a probiotic (VSL#3) for a 4 wk period followed by a 4 wk washout period. Oxalate load tests, providing a total of 80 mg oxalate, were conducted at baseline (pre-probiotic), and after the probiotic and washout periods. In the total subject population, mean total 22 h oxalate absorption at baseline (30.8 %) was significantly higher than after the probiotic (11.6 %) and washout (11.5 %) periods. However, four subjects identified as high oxalate absorbers at baseline had a particularly marked probiotic-induced reduction in oxalate absorption, which largely accounted for the reduction observed in the total subject population. The overall data suggested that in individuals characterized by high oxalate absorption levels, VSL#3 ingestion has the potential to reduce gastrointestinal oxalate absorption, which could decrease risk of kidney stones and other disorders related to hyperoxaluria.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224931     DOI: 10.1007/s00240-010-0262-9

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  48 in total

1.  Reduction of oxalate content of foods by the oxalate degrading bacterium, Eubacterium lentum WYH-1.

Authors:  H Ito; N Miura; M Masai; K Yamamoto; T Hara
Journal:  Int J Urol       Date:  1996-01       Impact factor: 3.369

Review 2.  Alterations in intestinal transport of oxalate in disease states.

Authors:  M Hatch; R W Freel
Journal:  Scanning Microsc       Date:  1995

Review 3.  Dietary oxalate and its intestinal absorption.

Authors:  R P Holmes; H O Goodman; D G Assimos
Journal:  Scanning Microsc       Date:  1995

4.  Intestinal oxalate absorption.

Authors:  H J Binder
Journal:  Gastroenterology       Date:  1974-09       Impact factor: 22.682

5.  Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers.

Authors:  Weiwen Chai; Michael Liebman; Susan Kynast-Gales; Linda Massey
Journal:  Am J Kidney Dis       Date:  2004-12       Impact factor: 8.860

6.  Characteristics of the transport of oxalate and other ions across rabbit proximal colon.

Authors:  M Hatch; R W Freel; N D Vaziri
Journal:  Pflugers Arch       Date:  1993-05       Impact factor: 3.657

7.  Intestinal excretion of oxalate in chronic renal failure.

Authors:  M Hatch; R W Freel; N D Vaziri
Journal:  J Am Soc Nephrol       Date:  1994-12       Impact factor: 10.121

8.  Oxalate degradation by intestinal lactic acid bacteria in dogs and cats.

Authors:  J S Weese; H E Weese; L Yuricek; J Rousseau
Journal:  Vet Microbiol       Date:  2004-07-14       Impact factor: 3.293

9.  Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test.

Authors:  Gerd E von Unruh; Susanne Voss; Tilman Sauerbruch; Albrecht Hesse
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

10.  Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones.

Authors:  David W Kaufman; Judith P Kelly; Gary C Curhan; Theresa E Anderson; Stephen P Dretler; Glenn M Preminger; David R Cave
Journal:  J Am Soc Nephrol       Date:  2008-03-05       Impact factor: 10.121

View more
  21 in total

1.  Acute probiotic ingestion reduces gastrointestinal oxalate absorption in healthy subjects.

Authors:  Ismail Al-Wahsh; Yan Wu; Michael Liebman
Journal:  Urol Res       Date:  2011-08-28

2.  Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria.

Authors:  Klara Klimesova; Jonathan M Whittamore; Marguerite Hatch
Journal:  Urolithiasis       Date:  2014-10-01       Impact factor: 3.436

Review 3.  The microbiome of the urinary tract--a role beyond infection.

Authors:  Samantha A Whiteside; Hassan Razvi; Sumit Dave; Gregor Reid; Jeremy P Burton
Journal:  Nat Rev Urol       Date:  2015-01-20       Impact factor: 14.432

4.  Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles.

Authors:  Takalani Theka; Allen Rodgers; Neil Ravenscroft; Sonja Lewandowski
Journal:  Urolithiasis       Date:  2013-01-22       Impact factor: 3.436

5.  Activity of probiotics from food origin for oxalate degradation.

Authors:  Nariman R Soliman; Baher A M Effat; Nayra Sh Mehanna; Nabil F Tawfik; Mohamed K Ibrahim
Journal:  Arch Microbiol       Date:  2021-07-20       Impact factor: 2.552

Review 6.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

7.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

8.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Endocr Pract       Date:  2013 Mar-Apr       Impact factor: 3.443

Review 9.  Probiotics and other key determinants of dietary oxalate absorption.

Authors:  Michael Liebman; Ismail A Al-Wahsh
Journal:  Adv Nutr       Date:  2011-04-30       Impact factor: 8.701

Review 10.  Oxalate nephropathy in systemic sclerosis: Case series and review of the literature.

Authors:  Colin B Ligon; Laura K Hummers; Zsuzsanna H McMahan
Journal:  Semin Arthritis Rheum       Date:  2015-07-02       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.